1-6 of 6
Kai Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma

Andrew B. Lassman, Patrick Y. Wen, Martin J. van den Bent, Scott R. Plotkin, Annemiek M.E. Walenkamp, Adam L. Green, Kai Li, Christopher J. Walker, Hua Chang, Sharon Tamir, Leah Henegar, Yao Shen, Mariano J. Alvarez, Andrea Califano, Yosef Landesman, Michael G. Kauffman, Sharon Shacham, Morten Mau-Sørensen
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (3): 452–460.
https://doi.org/10.1158/1078-0432.CCR-21-2225
Published: 01 February 2022
View article titled, A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
Open the PDF for A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer

Cameron M. Armstrong, Chengfei Liu, Liangren Liu, Joy C. Yang, Wei Lou, Ruining Zhao, Shu Ning, Alan P. Lombard, Jinge Zhao, Leandro S. D'Abronzo, Christopher P. Evans, Pui-Kai Li, Allen C. Gao
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (22): 6064–6074.
https://doi.org/10.1158/1078-0432.CCR-20-1682
Published: 13 November 2020
View article titled, Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer
Open the PDF for Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma

Yusheng Lin, Hongmei Dong, Weilun Deng, Wan Lin, Kai Li, Xiao Xiong, Yi Guo, Fuyou Zhou, Changchun Ma, Yuping Chen, Hongzheng Ren, Haijun Yang, Ningtao Dai, Lang Ma, Stephen J. Meltzer, Sai-Ching J. Yeung, Hao Zhang
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (10): 3035–3045.
https://doi.org/10.1158/1078-0432.CCR-18-3169
Published: 15 May 2019
View article titled, Evaluation of Salivary Exosomal Chimeric <em>GOLM1-NAA35</em> RNA as a Potential Biomarker in Esophageal Carcinoma
Open the PDF for Evaluation of Salivary Exosomal Chimeric <em>GOLM1-NAA35</em> RNA as a Potential Biomarker in Esophageal Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract POSTER-THER-1402: Overcoming platinum resistance in ovarian cancer with niclosamide

Rebecca C. Arend, MD, Abhishek Gangrade, Christen L. Walters Haygood, MD, Chandrika Kurpad, Brandon J. Metge, Rajeev S. Samant, PhD, Pui-Kai Li, PhD, Yonghe Li, PhD, Deepak Bhasin, PhD, Charles Landen, MD, Ronald Alvarez, MD, J. Michael Straughn, MD, Donald J. Buchsbaum, PhD
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16_Supplement): POSTER-THER-1402.
https://doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-THER-1402
Published: 15 August 2015
View article titled, Abstract POSTER-THER-1402: Overcoming platinum resistance in ovarian cancer with niclosamide
Journal Articles

Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3

Kuen-Feng Chen, Wei-Tien Tai, Tsung-Hao Liu, Hsiang-Po Huang, Yu-Chin Lin, Chung-Wai Shiau, Pui-Kai Li, Pei-Jer Chen, Ann-Lii Cheng
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (21): 5189–5199.
https://doi.org/10.1158/1078-0432.CCR-09-3389
Published: 31 October 2010
View article titled, Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
Open the PDF for Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3 in another window
Journal Articles

Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma

Wen-Yi Wang, Chih-Wen Twu, Hsin-Hong Chen, Jian-Sheng Jan, Rong-San Jiang, Jeffrey Y.C. Chao, Kai-Li Liang, Kuan-Wen Chen, Ching-Te Wu, Jin-Ching Lin
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (3): 1016–1024.
https://doi.org/10.1158/1078-0432.CCR-09-2796
Published: 01 February 2010
View article titled, Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma
Open the PDF for Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma in another window
Includes: Supplementary data